Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Podzamczer

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR studyA Ocampo, P Domingo, P Fernández, et al.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 12, 2022
Past and future of HIV infection. A document based on expert opinionE Bouza, J R Arribas, B Alejos, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patientsD Podzamczer, A Imaz, I Perez, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Vaccine|August 7, 2004
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsE Fernandez-Cruz, S Moreno, J Navarro, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR studyA Ocampo, P Domingo, P Fernández, et al.
Current HIV Research|June 22, 2012
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 yearsD Podzamczer, J M Tiraboschi, J Mallolas, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 12, 2022
Past and future of HIV infection. A document based on expert opinionE Bouza, J R Arribas, B Alejos, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2014
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patientsD Podzamczer, A Imaz, I Perez, et al.
Open Forum Infectious Diseases|March 3, 2022
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)D Podzamczer, R Micán, J Tiraboschi, et al.
Vaccine|August 7, 2004
Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjectsE Fernandez-Cruz, S Moreno, J Navarro, et al.
HIV Medicine|September 15, 2016
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in EuropeA Judd, R Lodwick, A Noguera-Julian, et al.
Pageof 11